vs
BATTALION OIL CORP(BATL)与RECURSION PHARMACEUTICALS, INC.(RXRX)财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是BATTALION OIL CORP的1.1倍($35.5M vs $31.6M),BATTALION OIL CORP净利率更高(5.7% vs -304.2%,领先309.9%),RECURSION PHARMACEUTICALS, INC.同比增速更快(681.7% vs -36.1%),过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高(60.5% vs -20.1%)
巴塔利昂石油公司是一家独立能源企业,核心业务为原油、天然气及天然气凝析液的勘探、开发与生产,主要运营资产位于美国得克萨斯州南部的伊格尔福特页岩区,服务北美能源市场的商业及工业客户。
Recursion Pharmaceuticals是一家临床阶段生物技术企业,依托人工智能技术和高通量生物实验体系,开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法,核心市场覆盖北美,与全球多家生物制药企业合作推进在研管线落地。
BATL vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.1倍
$31.6M
营收增速更快
RXRX
高出717.9%
-36.1%
净利率更高
BATL
高出309.9%
-304.2%
两年增速更快
RXRX
近两年复合增速
-20.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $31.6M | $35.5M |
| 净利润 | $1.8M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | -33.8% | -304.8% |
| 净利率 | 5.7% | -304.2% |
| 营收同比 | -36.1% | 681.7% |
| 净利润同比 | 108.1% | 39.6% |
| 每股收益(稀释后) | $-0.77 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BATL
RXRX
| Q4 25 | $31.6M | $35.5M | ||
| Q3 25 | $43.4M | $5.2M | ||
| Q2 25 | $42.6M | $19.2M | ||
| Q1 25 | $47.4M | $14.7M | ||
| Q4 24 | $49.5M | $4.5M | ||
| Q3 24 | $45.1M | $26.1M | ||
| Q2 24 | $49.1M | $14.4M | ||
| Q1 24 | $49.5M | $13.8M |
净利润
BATL
RXRX
| Q4 25 | $1.8M | $-108.1M | ||
| Q3 25 | $-735.0K | $-162.3M | ||
| Q2 25 | $4.8M | $-171.9M | ||
| Q1 25 | $6.0M | $-202.5M | ||
| Q4 24 | $-22.2M | $-178.9M | ||
| Q3 24 | $21.6M | $-95.8M | ||
| Q2 24 | $-105.0K | $-97.5M | ||
| Q1 24 | $-31.2M | $-91.4M |
毛利率
BATL
RXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率
BATL
RXRX
| Q4 25 | -33.8% | -304.8% | ||
| Q3 25 | 1.9% | -3327.6% | ||
| Q2 25 | -0.4% | -916.8% | ||
| Q1 25 | 7.2% | -1297.9% | ||
| Q4 24 | -36.2% | -4042.4% | ||
| Q3 24 | 2.3% | -377.1% | ||
| Q2 24 | 10.4% | -697.4% | ||
| Q1 24 | 0.0% | -698.4% |
净利率
BATL
RXRX
| Q4 25 | 5.7% | -304.2% | ||
| Q3 25 | -1.7% | -3135.3% | ||
| Q2 25 | 11.3% | -894.2% | ||
| Q1 25 | 12.7% | -1373.3% | ||
| Q4 24 | -44.9% | -3935.5% | ||
| Q3 24 | 48.0% | -367.5% | ||
| Q2 24 | -0.2% | -676.6% | ||
| Q1 24 | -63.0% | -662.4% |
每股收益(稀释后)
BATL
RXRX
| Q4 25 | $-0.77 | $-0.17 | ||
| Q3 25 | $-0.91 | $-0.36 | ||
| Q2 25 | $-0.21 | $-0.41 | ||
| Q1 25 | $-0.35 | $-0.50 | ||
| Q4 24 | $-1.47 | $-0.56 | ||
| Q3 24 | $0.34 | $-0.34 | ||
| Q2 24 | $-0.53 | $-0.40 | ||
| Q1 24 | $-2.24 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $28.0M | $743.3M |
| 总债务越低越好 | $208.1M | $9.6M |
| 股东权益账面价值 | $-32.8M | $1.1B |
| 总资产 | $460.7M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势,按日历期对齐
现金及短期投资
BATL
RXRX
| Q4 25 | $28.0M | $743.3M | ||
| Q3 25 | $50.5M | $659.8M | ||
| Q2 25 | $44.6M | $525.1M | ||
| Q1 25 | $73.6M | $500.5M | ||
| Q4 24 | $19.7M | $594.4M | ||
| Q3 24 | $29.8M | $427.6M | ||
| Q2 24 | $54.4M | $474.3M | ||
| Q1 24 | $48.9M | $296.3M |
总债务
BATL
RXRX
| Q4 25 | $208.1M | $9.6M | ||
| Q3 25 | $213.8M | $11.9M | ||
| Q2 25 | $219.4M | $14.2M | ||
| Q1 25 | $225.1M | $16.4M | ||
| Q4 24 | $162.1M | $19.0M | ||
| Q3 24 | $147.8M | $20.5M | ||
| Q2 24 | $160.4M | $22.9M | ||
| Q1 24 | $190.2M | — |
股东权益
BATL
RXRX
| Q4 25 | $-32.8M | $1.1B | ||
| Q3 25 | $-20.3M | $1.0B | ||
| Q2 25 | $-5.2M | $919.1M | ||
| Q1 25 | $-1.8M | $933.9M | ||
| Q4 24 | $4.1M | $1.0B | ||
| Q3 24 | $35.0M | $524.6M | ||
| Q2 24 | $22.7M | $584.4M | ||
| Q1 24 | $31.3M | $401.2M |
总资产
BATL
RXRX
| Q4 25 | $460.7M | $1.5B | ||
| Q3 25 | $491.7M | $1.4B | ||
| Q2 25 | $498.8M | $1.3B | ||
| Q1 25 | $506.2M | $1.3B | ||
| Q4 24 | $431.0M | $1.4B | ||
| Q3 24 | $458.0M | $726.5M | ||
| Q2 24 | $487.3M | $775.9M | ||
| Q1 24 | $488.6M | $557.8M |
负债/权益比
BATL
RXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | 39.35× | 0.02× | ||
| Q3 24 | 4.23× | 0.04× | ||
| Q2 24 | 7.07× | 0.04× | ||
| Q1 24 | 6.07× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-11.8M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | -6.58× | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势,按日历期对齐
经营现金流
BATL
RXRX
| Q4 25 | $-11.8M | $-46.1M | ||
| Q3 25 | $28.0M | $-117.4M | ||
| Q2 25 | $10.2M | $-76.4M | ||
| Q1 25 | $12.7M | $-132.0M | ||
| Q4 24 | $6.7M | $-115.4M | ||
| Q3 24 | $-5.1M | $-59.2M | ||
| Q2 24 | $29.8M | $-82.2M | ||
| Q1 24 | $3.9M | $-102.3M |
自由现金流
BATL
RXRX
| Q4 25 | — | $-47.3M | ||
| Q3 25 | — | $-117.6M | ||
| Q2 25 | — | $-79.6M | ||
| Q1 25 | — | $-133.8M | ||
| Q4 24 | — | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | — | $-83.4M | ||
| Q1 24 | — | $-109.0M |
自由现金流率
BATL
RXRX
| Q4 25 | — | -133.1% | ||
| Q3 25 | — | -2272.5% | ||
| Q2 25 | — | -413.9% | ||
| Q1 25 | — | -907.4% | ||
| Q4 24 | — | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | — | -578.5% | ||
| Q1 24 | — | -789.9% |
资本支出强度
BATL
RXRX
| Q4 25 | — | 3.5% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 48.2% |
现金转化率
BATL
RXRX
| Q4 25 | -6.58× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.13× | — | ||
| Q1 25 | 2.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.23× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BATL
| Oil | $28.6M | 91% |
| Natural Gas Liquids Reserves | $3.9M | 12% |
RXRX
暂无分部数据